Patent No. US10814137 (titled "Transcutaneous power conveyance device") on Feb 14, 2018. The application was issued on Oct 27, 2020.
’137 is related to the field of transcutaneous power delivery for medical devices, specifically for treating physiological disorders through neural modulation. The technology provides a mechanism to transfer energy from an external source to an implanted unit, which then stimulates or inhibits specific nerves—such as the hypoglossal nerve for sleep apnea or the occipital nerve for migraines—to manage conditions like obstructive sleep apnea, hypertension, and chronic headaches.
The underlying idea behind ’137 is the use of a modular, two-part external assembly that separates the disposable interface from the reusable electronics to ensure consistent energy transfer. By integrating a primary induction coil into a flexible, adhesive patch that mechanically locks onto a rigid electronics housing, the system maintains a stable spatial relationship between the power source and the internal implant while allowing the user to easily replace the adhesive component without discarding the expensive processing hardware.
The claims of ’137 focus on a device for treating sleep apnea comprising a flexible carrier designed to fit between a subject's chin and neck, featuring an adhesive on one side and a conductive coil for power transmission. The device is characterized by a mechanical connector that extends from the side of the carrier opposite the adhesive, specifically engineered to be received and held by a receiver on a separate electronics housing.
In practice, the flexible carrier acts as a skin-conforming interface that houses the primary antenna, which is often a double-layer crossover coil designed to minimize parasitic capacitance. The mechanical connector, which may take the form of a rodlike element, bayonet mount, or flexible extension arms, ensures that the electronics housing is not only physically secured but also electrically aligned with the antenna. This physical coupling allows the processor to monitor the degree of coupling between the external and internal coils, enabling the system to detect physiological movements—like the tongue shifting during an apnea event—and adjust power delivery in real-time.
This approach differs from prior solutions by providing a selective mechanical engagement that facilitates both rotation and secure retention without requiring the housing to be permanently fixed to the adhesive. Unlike traditional bulky straps or integrated one-piece patches, this design allows for a low-profile, breathable interface that can be precisely positioned. The use of redundant electrical contacts and circular exposed portions ensures that power and data flow remain uninterrupted even if the housing rotates, providing a robust and user-friendly solution for long-term neuromodulation therapy.
In the early 2010s when ’137 was filed, transcutaneous power transfer for medical implants was typically implemented using rigid external controllers or bulky inductive coils that required precise, often manual, alignment over the internal receiver. At a time when systems commonly relied on fixed external hardware or cumbersome wearable belts to maintain the inductive link, ensuring consistent energy coupling during patient movement was a significant challenge. Furthermore, when hardware constraints made the integration of power sources and control electronics into a low-profile, patient-adherent form factor non-trivial, most solutions resulted in significant mechanical strain on the skin or frequent decoupling of the power link.
The disclosed invention represents a technical advancement in the field of neuromodulation by decoupling the adhesive interface from the primary electronics housing through a modular, two-part architectural shift. By integrating an inductive coil directly into a flexible, adhesive carrier that features a dedicated mechanical connector, the system enables a stable and repeatable alignment between the external power source and the implanted device. This structural solution allows a separate processor housing to be securely mounted to and removed from the carrier, overcoming the constraint of balancing electronic complexity with the need for a lightweight, skin-conformable interface. The resulting technical effect is a robust transcutaneous power link that maintains efficiency during subject activity while facilitating the easy replacement of power or control components without disturbing the primary adhesive site.
The patent contains a total of 15 claims, with claim 1 serving as the sole independent claim. This independent claim focuses on a sleep apnea treatment device comprising a flexible carrier with an adhesive side, an internal power transmission coil for hypoglossal nerve modulation, and a mechanical connector for attaching an external housing. The dependent claims generally serve to specify various mechanical attachment mechanisms, electrical connection interfaces, housing configurations, and additional coil arrangements for the device.
Definitions of key terms used in the patent claims.
US Latest litigation cases involving this patent.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents